XML 88 R74.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Compensation (Summary of Outstanding Options Vesting, Expected to Vest, or Exercisable) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Mar. 25, 2023
Mar. 26, 2022
Mar. 27, 2021
Share-Based Payment Arrangement, Noncash Expense [Abstract]      
Number of Options, Vested and expected to vest (in shares) 709    
Weighted Average Exercise Price, Vested and expected to vest (in dollars per share) $ 68.63    
Weighted Average Remaining Contractual Term, Vested and expected to vest 6 years 8 months 1 day    
Aggregate Intrinsic Value, Vested and expected to vest $ 26,208    
Number of Options, Exercisable (in shares) 452 600 700
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 57.01    
Weighted Average Remaining Contractual Term, Exercisable 5 years 4 months 13 days    
Aggregate Intrinsic Value, Exercisable $ 21,955